Detailed information for compound 980312

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 386.486 | Formula: C25H26N2O2
  • H donors: 0 H acceptors: 2 LogP: 5.97 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc2c(n1)c(OCCCCCOc1cccc3c1nc(C)cc3)ccc2
  • InChi: 1S/C25H26N2O2/c1-18-12-14-20-8-6-10-22(24(20)26-18)28-16-4-3-5-17-29-23-11-7-9-21-15-13-19(2)27-25(21)23/h6-15H,3-5,16-17H2,1-2H3
  • InChiKey: CPKBZWNWVLFYCW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis Clan CA, family C1, cathepsin B-like cysteine peptidase 0.0139 0 0.5
Plasmodium falciparum dipeptidyl aminopeptidase 1 0.0225 1 0.5
Toxoplasma gondii preprocathepsin c precursor, putative 0.0225 1 0.5
Schistosoma mansoni dipeptidyl-peptidase I (C01 family) 0.0225 1 0.5
Plasmodium falciparum dipeptidyl aminopeptidase 2 0.0225 1 0.5
Plasmodium vivax dipeptidyl aminopeptidase 1, putative 0.0225 1 0.5
Plasmodium vivax dipeptidyl aminopeptidase 2, putative 0.0225 1 0.5
Toxoplasma gondii cathepsin CPC1 0.0225 1 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 82 % Antileishmanial activity against Leishmania donovani MHOM/IN/1983/AG83 promastigotes infected ip dosed BALB/c mouse assessed as reduction in spleen parasite burden administered two times per week for 4 weeks relative to control ChEMBL. 18538452
Activity (functional) = 88.5 % Antileishmanial activity against Leishmania donovani MHOM/IN/1983/AG83 promastigotes infected ip dosed BALB/c mouse assessed as reduction in liver parasite burden administered two times per week for 4 weeks relative to control ChEMBL. 18538452
Activity (functional) = 135 mg Antileishmanial activity against Leishmania donovani MHOM/IN/1983/AG83 promastigotes infected BALB/c mouse assessed as spleen weight at 12.5 mg/kg, ip administered two times per week for 4 weeks ChEMBL. 18538452
Activity (functional) = 1020 mg Antileishmanial activity against Leishmania donovani MHOM/IN/1983/AG83 promastigotes infected BALB/c mouse assessed as liver weight at 12.5 mg/kg, ip administered two times per week for 4 weeks ChEMBL. 18538452
IC50 (functional) = 2.4 ug ml-1 Antileishmanial activity against Leishmania donovani MHOM/IN/1983/AG83 amastigotes by Giemsa staining ChEMBL. 18538452
IC50 (functional) = 2.8 ug ml-1 Antileishmanial activity against Leishmania donovani MHOM/IN/1983/AG83 promastigotes after 4 hrs by MTT assay ChEMBL. 18538452

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Leishmania donovani ChEMBL23 18538452

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.